- Home
- SMLR vs ADCT Comparison
SMLR vs ADCT Comparison
Compare SMLR & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- ADCT
- Stock Information
- Founded
- SMLR 2007
- ADCT 2011
- Country
- SMLR United States
- ADCT Switzerland
- Employees
- SMLR N/A
- ADCT N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- SMLR Health Care
- ADCT Health Care
- Exchange
- SMLR Nasdaq
- ADCT Nasdaq
- Market Cap
- SMLR 289.5M
- ADCT 285.2M
- IPO Year
- SMLR 2014
- ADCT 2020
- Fundamental
- Price
- SMLR $57.02
- ADCT $2.42
- Analyst Decision
- SMLR
- ADCT Strong Buy
- Analyst Count
- SMLR 0
- ADCT 5
- Target Price
- SMLR N/A
- ADCT $7.33
- AVG Volume (30 Days)
- SMLR 1.0M
- ADCT 458.4K
- Earning Date
- SMLR 11-04-2024
- ADCT 11-07-2024
- Dividend Yield
- SMLR N/A
- ADCT N/A
- EPS Growth
- SMLR N/A
- ADCT N/A
- EPS
- SMLR 2.04
- ADCT N/A
- Revenue
- SMLR $58,938,000.00
- ADCT $70,717,000.00
- Revenue This Year
- SMLR N/A
- ADCT $6.38
- Revenue Next Year
- SMLR N/A
- ADCT $11.73
- P/E Ratio
- SMLR $27.98
- ADCT N/A
- Revenue Growth
- SMLR N/A
- ADCT N/A
- 52 Week Low
- SMLR $20.88
- ADCT $0.86
- 52 Week High
- SMLR $79.45
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- SMLR 60.19
- ADCT 45.56
- Support Level
- SMLR $52.00
- ADCT $1.91
- Resistance Level
- SMLR $63.29
- ADCT $2.38
- Average True Range (ATR)
- SMLR 9.23
- ADCT 0.23
- MACD
- SMLR 0.41
- ADCT -0.01
- Stochastic Oscillator
- SMLR 38.18
- ADCT 46.67
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.